Astral Limited reports 52% net profit surge in Q1FY27
Astral Limited delivered robust Q1FY27 results with net profit surging 52% to ₹1,202 million and EBITDA growing 26% to ₹2,440 million. The Plumbing segment led growth with improved margins, while Paints and Adhesives saw significant revenue expansion. Strategic initiatives include capacity expansion and the acquisition of DSS.
*this image is generated using AI for illustrative purposes only.
Astral Limited reported a consolidated net profit of ₹1,202 million for the quarter ended June 30, 2026 (Q1FY27), marking a 51.8% year-on-year increase from ₹792 million in the corresponding period of FY26. Consolidated revenue from operations grew 15.9% to ₹15,780 million, while EBITDA expanded 25.8% to ₹2,440 million, reflecting improved operational leverage despite a weak industry demand scenario in the plastic pipe sector.
The Board of Directors approved the unaudited standalone and consolidated financial results on August 12, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by the Statutory Auditors, S R B C & Co LLP. Standalone net profit stood at ₹1,358 million, up 40.6% from ₹966 million in Q1FY26, with standalone revenue rising 13.3% to ₹13,678 million.
Segment Performance
The Plumbing segment remained the primary growth engine, with revenue increasing 10.1% YoY to ₹10,505 million. Despite industry demand falling approximately 10% due to polymer price volatility, Astral gained market share, achieving flat volume growth of 0.1% (56,146 M.T.) but higher value realizations. Segment EBITDA surged 26.7% to ₹1,983 million, with margins expanding to 18.9% from 16.4% in Q1FY26, the highest among industry players.
The Paints and Adhesives segment posted robust revenue growth of 29.5% to ₹5,275 million. This was driven by a 48.7% surge in Paints sales and 24.9% growth in Adhesives. Segment EBITDA rose 21.9% to ₹457 million, though margins contracted slightly to 8.7% from 9.2% due to raw material cost pressures.
| Segment | Revenue (₹ Million) | YoY Change | EBITDA (₹ Million) | EBITDA Margin |
|---|---|---|---|---|
| Plumbing | 10,505 | +10.1% | 1,983 | 18.9% |
| Paints and Adhesives | 5,275 | +29.5% | 457 | 8.7% |
| Total | 15,780 | +15.9% | 2,440 | 15.5% |
Strategic Developments and Outlook
Astral expanded its Pipes and Fittings production capacity from 417,645 M.T. to 421,497 M.T. during the quarter. The new CPVC Resin plant (Phase I, 40,000 M.T.) is progressing as per schedule, with trial runs expected in Q4FY27 and full benefits anticipated from FY28 onwards. This vertical integration is expected to improve margins and gain market share in CPVC pipes and fittings.
In the Adhesives business, New Bharat accelerated rural expansion, adding over 8,000 towns and taking direct dealers beyond 1,500. The International Adhesive Business grew 26% YoY, delivering an EBITDA margin of 4.9%. Additionally, Astral Chemie Limited acquired a 60% stake in Differentiated & Sustainable Solutions LLP (DSS) for an upfront payment of ₹391 million. DSS contributed ₹67 million in sales and ₹9 million in EBITDA in its first quarter, expanding Astral’s portfolio into Specialty Chemicals.
What the Numbers Show
The divergence between flat volume growth in Plumbing and double-digit revenue growth highlights successful price realization strategies amidst volatile polymer costs. The expansion in EBITDA margins to 15.5% from 14.3% in Q1FY26, coupled with a PAT margin improvement to 7.6% from 5.8%, indicates strong operational efficiency. The acquisition of DSS marks a strategic shift towards high-value specialty chemicals, diversifying revenue streams beyond traditional plumbing and paints.
Historical Stock Returns for Astral
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.74% | +1.10% | +10.00% | -8.05% | +5.96% | -0.72% |
How will the upcoming trial runs of the CPVC Resin plant in Q4FY27 impact Astral's cost structure and competitive positioning in the high-margin CPVC pipe market?
Given the 10% decline in overall industry demand, what specific strategies is Astral employing to sustain its market share gains in the Plumbing segment beyond price realization?
What is the projected timeline for synergy realization from the acquisition of DSS, and how significant will Specialty Chemicals become as a revenue contributor relative to core businesses?
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
